Gustav Stålhammar

Gustav Stålhammar

Affiliated to Research | Docent
Visiting address: Eye Center of Excellence Avd Ögon & Syn, Eugeniavägen 12, 17164 Solna
Postal address: K8 Klinisk neurovetenskap, K8 Ögon och Syn Stålhammar, 171 77 Stockholm
Part of:

About me

  • Associate professor of ophthalmology
    Research group leader
    M.D. Ph.D. FEBO
    Board certified ophthalmologist
    Board certified pathologist
    Director, St. Erik Ophthalmic Pathology Laboratory
    Board member, Edwin Jordan foundation for ophthalmological research
    Board member, Fru Karin Sandqvist foundation

Research

  • My research is focused on predicting and preventing death from ocular tumors. Uveal melanoma is the most common primary intraocular tumor in adults. Almost half of all patients develop metastases even if the eye has been removed. This is believed to be due to so-called micrometastases that leave the primary tumor very early. These micrometastases can remain dormant in their metastatic niche, including the bone marrow and liver, for several years. Once they leave dormancy and start growing, the patient’s prognosis is poor with a median survival of only 4–15 months. Uveal melanoma is thereby a cancer disease with unpredictable, high mortality and limited treatment options. I would like to help remedy this.

    I am the Principal Investigator in the world's longest randomized trial of adjuvant treatment for uveal melanoma
    - AMUM (https://clinicaltrials.gov/study/NCT05502900)

    Similarly, I am trying to expand our knowledges about retinoblastoma – the most common intraocular tumor in children. In national and international
    collaborations, we are investigating how chromosomal and genetic aberrations influence survival, and use digital image analysis to find changes in cell size and shape that correlate with a poor prognosis.

Articles

All other publications

Employments

  • Affiliated to Research, Department of Clinical Neuroscience, Karolinska Institutet, 2023-2026

Degrees and Education

  • Docent, Karolinska Institutet, 2020
  • Degree Of Doctor Of Philosophy, Department of Oncology-Pathology, Karolinska Institutet, 2017

News from KI

Events from KI